Understanding the genomic complexity of lung cancer along with early screening can lead to improved outcomes. Dr. Powell discusses clinical issues in lung cancer and the mechanisms that drive clinical phenomena, as well as the role of molecular biomarkers and the immune environment.
Related Presenters
Janice and Coleman Rabin Professor of Medicine
System Chief, Pulmonary, Critical Care and Sleep Medicine
CEO, Mount Sinai – National Jewish Health Respiratory Institute
Related Videos
